Latest Psychedelic Science Research Papers | Page 4 | OpenScience.ink

3 weeks ago • Frontiers in psychiatry

Participants' experiences with ketamine-assisted therapy for methamphetamine addictionNavigating 'k-land': a qualitative exploration of participants' experiences of ketamine-assisted psychotherapy for methamphetamine use disorder.

📖 Top 20% Journal

3 weeks ago • The International journal on drug policy

Canadians' knowledge and views on psychedelic drug stores, their rules, and public healthPsychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.

🎖️ Top 10% Journal

4 weeks ago • The International journal on drug policy

Why Addressing Negative Expectations Matters More Than Keeping Trials Blind in Psychedelic StudiesRedefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity.

🎖️ Top 10% Journal

4 weeks ago • Molecular psychiatry

Increased serotonin 1B receptor binding after ketamine and electroconvulsive therapy across multiple centersConvergent increases in serotonin 1B receptor binding following ketamine and electroconvulsive therapy: a multi-centre bayesian re-analysis of PET data.

🥈 Top 2% Journal

4 weeks ago • BMJ case reports

Long-term ketamine use linked to worsening problems in multiple organsChronic ketamine use associated with progressive multisystem organ dysfunction.

4 weeks ago • Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Psilocybin therapy lowers brain chemicals galanin and noradrenaline in major depressionCSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.

🥉 Top 5% Journal

4 weeks ago • The British journal of psychiatry : the journal of mental science

Psilocybin therapy in adult women with anorexia nervosa: pilot studyPsilocybin therapy for adult females with anorexia nervosa: pilot study.

🥉 Top 5% Journal

4 weeks ago • Pharmacopsychiatry

Ketamine's link to thinking skills in people with hard-to-treat depressionAssociation between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.

4 weeks ago • BMC medicine

Australian healthcare professionals’ views on using psilocybin to ease cancer-related existential distressThe need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.

🥉 Top 5% Journal

1 month ago • Therapeutic advances in psychopharmacology

Ketamine changes brain signal patterns in major depression, which may relate to brain excitation-inhibition balance and help predict treatment responseKetamine alters the aperiodic EEG exponent in major depression: implications for cortical E/I balance and treatment prediction.

📖 Top 20% Journal

1 month ago • The British journal of psychiatry : the journal of mental science

Effectiveness and safety of repeated under-the-skin ketamine for hard-to-treat depression and how past ketamine use may affect resultsEffectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

🥉 Top 5% Journal

1 month ago • BMJ open

MDMA-assisted therapy combined with exposure treatment for people with both PTSD and alcohol use disorder: study plan for a double-blind outpatient trialMDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.

📖 Top 20% Journal

1 month ago • The international journal of neuropsychopharmacology

Ketamine's effects on brain activity and therapy links vary in treatment-resistant depression, PTSD, and OCDKetamine effects on EEG and their links to therapy differ across treatment-resistant major depression, post-traumatic stress disorder, and obsessive-compulsive disorder.

🎖️ Top 10% Journal

1 month ago • The International journal on drug policy

Canada's changing policies and history of psychedelic use for end-of-life distressPolicy pathways and historical insights: Canada's evolving approach to psychedelic access for end-of-life distress.

🎖️ Top 10% Journal

← prevpage 4 of 4next →